This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish (read more).

Clinical Services

Aseptic Fill Finish Processing

PCI Clinical Services can offer customised manufacturing of aseptic fill finish treatments for conducting all of your Phase I clinical trials in Australia.

From our dedicated and fully audited facilities in Melbourne, Australia we provide specialized sterile technologies that ensure flexibility, accuracy and speed to market.

  • Aseptic/Sterile Fill for phase 1 Clinical Trials
  • Full randomisation/blinding and delivery to Phase I site “ready to use”
  • Prefilled syringes & Vials (2ml, 5mL, 10mL, 20mL)
  • Infusion bags and syringe pumps
  • Manufactured in excess of 200 batches
  • Peptides, NCEs, biologicals
  • Complex peptide formulations
  • Single use Millipore systems
  • USP Sterility and Endotoxin Testing
  • Filter integrity testing (bubble point)
  • Continuous particulate testing
  • In process assay, pH, appearance
  • Grade C formulation suite
  • HEPA filtered pass throughs
  • Grade B filling suite with Grade A laminar flow
  • Full time microbiologist
  • Trained staff in aseptic processing
  • Full time environmental monitoring staff

Our dedicated team of specialists will be happy to discuss any of our Aseptic Fill and Finish processes with you. Contact us on +1 779-774-1428 (US) or +44 1495 711 222 (UK) or email

PCI Pharma Services Completes Expansion of its Specialty Drug Product Capabilities at Rockford, IL Site

Increases Capacity at State-of-the-Art Facility in Response to Growing Market Needs PHILADELPHIA–(BUSINESS WIRE)–PCI Pharma Services (PCI), a leading pharmaceutical and... View Article

PCI Unveils Clinical Center of Excellence

Expanded Clinical Services Facility in Rockford, IL to Support Growth and Flexibility with 30,000 additional sq ft We have officially... View Article